Ingelheim, Germany / Ridgefield, Connecticut, U.S. Data from the Phase Ib Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients with advanced HER2 (ERBB2)-mutant NSCLC were presented ...
Solar-powered calculators may have familiarized a new generation with green energy. On the other hand, maybe they were just cool.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback